Trident Digital Tech Holdings Ltd. has been notified by Nasdaq that it has regained compliance with the minimum Market Value of Listed Securities (MVLS) requirement. The company's MVLS has been at or above US$35,000,000 for 10 consecutive business days from September 8 to September 21, 2026. This resolves the non-compl...

Heiko Schipper, Business Group President of Foods at Unilever PLC, has sold 345 ordinary shares of Unilever PLC in EUR on September 23, 2026, at a price of €54.79 per share. The total volume of the transaction was 345 shares, amounting to €18,902.55. The transaction took place on Euronext Amsterdam (XAMS). This is an i...

Uxin Limited reported its unaudited financial results for the quarter ended June 30, 2026. The company experienced a significant increase in transaction volume, up 88.7% year-over-year to 21,899 units, with retail volume up 88.8% to 19,610 units. Total revenues increased by 74.9% year-over-year to RMB 1,151.2 million. ...

Vale S.A. announced the partial resumption of operations at its Fábrica Mine in Ouro Preto, Minas Gerais. This resumption is authorized by the Court of Justice of the State of Minas Gerais and is based on a Commitment Agreement between Vale, the State Public Prosecutor's Office, and the State of Minas Gerais. Operation...

Vertical Aerospace Ltd. announced on September 24, 2026, that it has begun a review of strategic alternatives, including potential strategic and financial partnerships. This review aims to advance the company's next stage of development. Jefferies LLC has been retained as the financial advisor for this process. The com...

Waldencast plc has filed a Form 25 with the SEC to voluntarily delist its Class A Ordinary Shares and Warrants from the Nasdaq Stock Market. The delisting is expected to be effective around October 4, 2026, with the last trading day anticipated to be October 2, 2026. Concurrently, the company plans to file a Form 15 to...

WeRide Inc. announced on September 23, 2026, the grant of 17,880,200 Restricted Share Units (RSUs) to 160 grantees, including its founder Dr. Han and co-founder Dr. Li, as well as 158 other employees. The RSUs were granted under the 2026 Share Plan, with no purchase price. The closing price of Class A Ordinary Shares o...

Yimutian Inc. announced the completion of two previously disclosed acquisitions: the Qingdao Xingongguan Acquisition, involving 100% equity interests for US$5,800,000 paid in Class A ordinary shares, and the Zhaodong Guohe Asset Acquisition, for US$21,161,390 paid in Class A ordinary shares. Additionally, the company c...

This report details ZenaTech, Inc.'s unaudited consolidated financial statements for the six months ended June 30, 2026, and compares them to the same period in 2025. The company experienced significant revenue growth, particularly in its Drone as a Service (DaaS) segment, driven by numerous acquisitions. Despite incre...

This report details the findings of a Preliminary Economic Assessment (PEA) for the Albany Graphite Project, indicating a potential after-tax Net Present Value (NPV) of US$3.85 billion and an Internal Rate of Return (IRR) of 27.4% at a 5% discount rate. The project involves an initial capital investment of US$817 milli...

Zhihu Inc. is holding an Extraordinary General Meeting (EGM) on October 20, 2026, to approve a significant transaction: the subscription for a limited partnership interest in Tianjin Lisi Xingshen Equity Investment Partnership (Limited Partnership) with a capital commitment of RMB1.5 billion. This investment is intende...

On September 23, 2026, AC Immune SA announced positive safety and immunogenicity results from the 100-week data set of Part 1 of its VacSYn Phase 2 trial. The study evaluated ACI-7104, an active immunotherapy targeting alpha-synuclein (a-syn), in 34 patients with early-stage Parkinson’s disease. The trial met all prima...

Alterity Therapeutics Limited, a development-stage biotechnology company, filed a Form 6-K with the SEC on September 23, 2026. The primary purpose of the filing was to submit a Corporate Presentation for September 2026 as Exhibit 99.1. The presentation is intended to provide updates on the company\'s operations and pro...

AstraZeneca PLC announced that Trixeo Aerosphere has received approval in the European Union for the maintenance treatment of asthma in patients aged 12 and older. This marks the first triple-combination therapy in a single inhaler approved in the EU for asthma patients, regardless of exacerbation history. The approval...

AerCap Holdings N.V., through its wholly-owned subsidiary AerCap Funding Designated Activity Company, has priced an offering of $1.5 billion in senior notes. The offering includes $750 million of 5.500% Senior Notes due 2030 and $750 million of 5.875% Senior Notes due 2033. These notes are fully and unconditionally gua...

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) announced a partial execution of its share capital reduction, approved by the Ordinary General Shareholders’ Meeting on March 20, 2026. The reduction involves the cancellation of 70,339,213 own shares, with a nominal value of €34,466,214.37, held as treasury shares. These sh...

Banco Santander-Chile reported a material event regarding a change in its Board of Directors. Following the resignation of alternate director Alfonso Gómez Morales on September 10, 2026, the Board of Directors appointed Mr. Javier Maldonado Trinchant as the new alternate director. This appointment was resolved during t...

This Form 6-K filing by Brookfield Corporation details the underwriting agreement for Brookfield Finance Inc.'s 5.650% Notes due 2031. The agreement outlines the terms and conditions under which several underwriters, represented by designated representatives, will purchase these debt securities from Brookfield Finance ...

This filing details the Fourteenth Supplemental Indenture between Brookfield Finance Inc. (Issuer), Brookfield Corporation (Company), and Computershare Trust Company of Canada (Trustee). The indenture, dated September 23, 2026, authorizes the issuance of 5.650% Notes due 2031, with an aggregate principal amount initial...

This filing, dated September 2026, reports on Baidu, Inc.'s "Next Day Disclosure Return" concerning changes in issued shares. The company repurchased 552,450 ordinary shares on September 22, 2026, for an aggregate price of HKD 49,995,841.08. These repurchases were conducted on the exchange, with prices ranging from HKD...

Blue Moon Metals Inc. has signed a definitive agreement to acquire 100% of the Turner Copper-Gold deposit in Oregon from Gold Coast Mining Inc. The Turner deposit is a past-producing volcanic massive sulphide (VMS) deposit, similar to Blue Moon's existing Blue Moon Mine in California. The company plans to advance Turne...

Bon Natural Life Limited reported its unaudited financial results for the six months ended March 31, 2026. Total revenues increased by 1.9% to $8,097,810 compared to the same period in 2025. However, the company experienced a significant shift in profitability, with a loss from operations of $8,575,392 for the six mont...

This filing provides a comprehensive overview of the company's financial position and performance for the period ending June 30, 2026. It details various financial instruments, including loans, notes, and derivatives, along with their carrying amounts and fair value assessments. The report segments operational data, hi...

This document outlines the bylaws of Companhia de Saneamento Básico do Estado de São Paulo - SABESP. It details the company's corporate name, principal place of business, corporate purpose, and duration. The bylaws also cover share capital, shares, general meetings, and the management structure, including the Board of ...

Cybin Inc. (d/b/a Helus Pharma) announced the results of its Annual and Special Meeting of Shareholders held on September 22, 2026. Shareholders approved a legal name change from 'Cybin Inc.' to 'Helus Pharma Inc.', effective October 1, 2026. This transition reflects the company's evolution from a clinical-stage discov...